Navigation Links
Moderate Drinking may Lower Risk of Kidney Cancer

Moderate drinking may lower the risk of a type of kidney malignancy called renal cancer according to a study .

The researchers at Brigham and Women's Hospital in Boston found that women and men who drank an average of one alcoholic beverage a day were about 30 percent less likely to develop renal cell cancer than non-drinkers. This reduced risk they found in people who drank beer, wine or liquor.

Jung Eun Lee and other researchers reviewed data from 12 studies that included more than 7,50,000 people in five countries.

The researchers, however, insisted that no smoking and maintaining a healthy weight are the best ways to protect from the disease.

They noted that alcohol raises the risk of cancers of the oral cavity, larynx, throat, esophagus, liver and breast, and possibly the colon and rectum and the best way to reduce the risk is to say no to smoking and maintaining a healthy weight, reported health portal Health Central.

"These healthy lifestyle choices (not smoking, weight control) should be encouraged, and doing so may also reduce the risk of many other cancers as well as cardiovascular disease," Lee said in the study that appeared in the May 16 issue of the Journal of the National Cancer Institute.


'"/>




Page: 1

Related medicine news :

1. Moderate Use of Analgesics - Not Associated With Kidney Dysfunction
2. Moderate alcohol consumption protects against dementia
3. Moderate Exercise may not help prevent Heart Disease
4. The Benefits Of A Diet Consisting Of Moderate Amounts Of Fat
5. Moderate drinking can be good for the kidneys
6. Enjoy Moderate Exercise and Keep Your Heart Fit
7. Even Moderate Drinking Is Not Good For The Heart
8. Moderate Drinkers Found to Escape Obesity and Related Problems
9. Moderate Exercise Is Good For The Heart: Study
10. Moderate Drinking Can Help Cut Diabetes Risk In Middle-Aged Women
11. Moderate Drinking Does Not Guard Against Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are held ... with process innovation in drug formulation and manufacturing. CoreRx offers its clients ... equipment in support of their development and manufacturing goals. , The company ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers ... back pain with a reputable physician in their area, announces the launch of a ... information for patients who are looking for reputable physicians to help them with back ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest ... chronic problems, I focus on preventative care with all my patients to alleviate possible future ... always feel free to contact my office and my trained staff will assist you in ...
(Date:4/25/2017)... ... April 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency ... Series, Outliers in Writing, set to publish in summer 2017. , Dr. Bobrow, ... University of Arizona College of Medicine. He also serves as Medical Director for the ...
(Date:4/25/2017)... ... ... Vetoquinol USA® , a world-class developer of veterinarian-approved ... EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin UCII ... The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and joints. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: ... that address significant unmet medical needs, today announced ... Company,s consumer product development program, based on its ... for Investigative Dermatology (SID) 76 th Annual ... promote the sciences relevant to skin health and ...
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
Breaking Medicine Technology: